Evidence map›Paper›PMID 31349540›Full record

ArticleViruses2019

Deletions in Genes Participating in Innate Immune Response Modify the Clinical Course of Andes Orthohantavirus Infection.

Grazielle Esteves Ribeiro, Luis Edgardo Leon, Ruth Perez, Analia Cuiza, Pablo Agustin Vial, Marcela Ferres, Gregory J Mertz, Cecilia Vial

Abstract read
In one paragraph

Article in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Transient Andes orthohantavirus RNA detection in an asymptomatic healthcare worker following indirect exposure during hospital care of an imported case, the Netherlands, 2026.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Identification of mFrontiers in cell and developmental biology · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Grazielle Esteves RibeiroPrograma Hantavirus, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Av. La Plaza 680, Las Condes, Región Metropolitana 7500000, Chile.
Luis Edgardo LeonInstituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Pedro de Valdivia 425, Región Metropolitana 7500000, Santiago, Chile.
Ruth PerezPrograma Hantavirus, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Av. La Plaza 680, Las Condes, Región Metropolitana 7500000, Chile.
Analia CuizaPrograma Hantavirus, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Av. La Plaza 680, Las Condes, Región Metropolitana 7500000, Chile.
Pablo Agustin VialPrograma Hantavirus, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Av. La Plaza 680, Las Condes, Región Metropolitana 7500000, Chile.
Marcela FerresDepartamento de Enfermedades Infecciosas e Inmunología Pediátricas, Pontificia Universidad Católica de Chile, Marcoleta 391, Santiago, Región Metropolitana 7500000, Chile.
Gregory J MertzDepartment of Internal Medicine, MSC10 5550, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA.
Cecilia VialPrograma Hantavirus, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Av. La Plaza 680, Las Condes, Región Metropolitana 7500000, Chile. mcvial@udd.cl.ORCID 0000-0002-0399-6144

Funding

Virology/Immunology CoreU19AI045452 · NIAID · UNIVERSITY OF NEW MEXICO · PI MERTZ, GREGORY JAMES · 1999 to 2009
$8.7M
NIAID NIH HHS 5UI9AI045452
6 · The paper itself

Abstract

Andes orthohantavirus (ANDV) is an important human pathogen causing hantavirus cardiopulmonary syndrome (HCPS) with a fatality rate of 30% in Chile. Around 60% of all cases have a severe clinical course, while the others have a mild clinical course. The main goal of this study was to understand if the genetic variation of patients is associated with the clinical course they develop after ANDV infection. For this, the frequency of copy number variants (CNVs, i.e., deletions and duplications) was studied in 195 patients, 88 with mild and 107 with severe HCPS. CNVs were called from intensity data of the Affymetrix Genome-Wide SNP Array 6.0. The analysis of the data was performed with PennCNV, ParseCNV and R softwares; Results: a deletion of 19, 416 bp in the q31.3 region of chromosome 1 is found more frequently in severe patients (

Indexed as

Genetic Predisposition to DiseaseSequence DeletionAgedChileComplement Factor HDNA Copy Number VariationsFemaleGenetic VariationGenotypeHantavirus InfectionsHumansImmunity, InnateMaleMiddle AgedOligonucleotide Array Sequence AnalysisOrthohantavirusComplement Factor HReceptors, Cell SurfaceSIRPB1 protein, humanANDVhantavirusHCPS

Identifiers

PMID31349540
PMCPMC6723883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.